Skip Nav Destination
Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy
Elastic tissue abnormalities resembling pseudoxanthoma elasticum in β thalassemia and the sickling syndromes
The hypercoagulable state in thalassemia
Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members
Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies
Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1–associated myelopathy (HAM/TSP)
Liposomal amphotericin B (AmBisome) compared with amphotericin B ± FMLP induces significantly less in vitro neutrophil aggregation with granulocyte–colony-stimulating factor/dexamethasone–mobilized allogeneic donor neutrophils: Presented in part at the American Society of Blood and Marrow Transplantation, Keystone, CO, February 2001
Issue Archive
January 1 2002
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy
Clinical Trials & Observations
Russell E. Ware,Barry Eggleston,Rupa Redding-Lallinger,Winfred C. Wang,Kim Smith-Whitley,Charles Daeschner,Beatrice Gee,Lori A. Styles,Ronald W. Helms,Thomas R. Kinney,Kwaku Ohene-Frempong
ERRATA
REVIEW ARTICLES
Elastic tissue abnormalities resembling pseudoxanthoma elasticum in β thalassemia and the sickling syndromes
Clinical Trials & Observations
The hypercoagulable state in thalassemia
Clinical Trials & Observations
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members
Clinical Trials & Observations
Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma
Clinical Trials & Observations
Stephen M. Ansell,Thomas E. Witzig,Paul J. Kurtin,Jeff A. Sloan,Diane F. Jelinek,Kyle G. Howell,Svetomir N. Markovic,Thomas M. Habermann,George G. Klee,Pamela J. Atherton,Charles Erlichman
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies
Clinical Trials & Observations
Paolo Corradini,Corrado Tarella,Attilio Olivieri,Alessandro M. Gianni,Claudia Voena,Francesco Zallio,Marco Ladetto,Michele Falda,Moira Lucesole,Anna Dodero,Fabio Ciceri,Fabio Benedetti,Alessandro Rambaldi,Maria R. Sajeva,Moreno Tresoldi,Alessandro Pileri,Claudio Bordignon,Marco Bregni
Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1–associated myelopathy (HAM/TSP)
Clinical Trials & Observations
Yoshihisa Yamano,Masahiro Nagai,Meghan Brennan,Carlos A. Mora,Samantha S Soldan,Utano Tomaru,Norihiro Takenouchi,Shuji Izumo,Mitsuhiro Osame,Steven Jacobson
HEMATOPOIESIS
Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects
Xu-Ming Dai,Gregory R. Ryan,Andrew J. Hapel,Melissa G. Dominguez,Robert G. Russell,Sara Kapp,Vonetta Sylvestre,E. Richard Stanley
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Human T-cell leukemia virus type 2 induces survival and proliferation of CD34+ TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-γ and granulocyte macrophage–colony-stimulating factor
Chiara Bovolenta,Elisabetta Pilotti,Massimiliano Mauri,Marco Turci,Paolo Ciancianaini,Paola Fisicaro,Umberto Bertazzoni,Guido Poli,Claudio Casoli
NEOPLASIA
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
Bellinda A. Bladergroen,Chris J. L. M. Meijer,Rosita L. ten Berge,C. Erik Hack,Jettie J. F. Muris,Danny F. Dukers,Andreas Chott,Yoshiaki Kazama,Joost J. Oudejans,Oskar van Berkum,J. Alain Kummer
ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances
Emma Camacho,Luis Hernández,Silvia Hernández,Frederic Tort,Beatriz Bellosillo,Silvia Beà,Francesc Bosch,Emili Montserrat,Antonio Cardesa,Pedro L. Fernández,Elias Campo
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome
Christian M. Zwaan,Gertjan J. L. Kaspers,Rob Pieters,Karel Hählen,Gritta E. Janka-Schaub,Christina H. van Zantwijk,Dieuwke R. Huismans,Esther de Vries,Marianne G. Rots,Godefridus J. Peters,Gerrit Jansen,Ursula Creutzig,Anjo J. P. Veerman
Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells
Elisabeth Oelmann,Hermann Herbst,Michael Zühlsdorf,Oliver Albrecht,Annette Nolte,Christiane Schmitmann,Oliver Manzke,Volker Diehl,Harald Stein,Wolfgang E. Berdel
Ataxia telangiectasia mutated–deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage
Tatjana Stankovic,Grant S. Stewart,Christopher Fegan,Paul Biggs,James Last,Philip J. Byrd,Russell D. Keenan,Paul A. H. Moss,Alexander M. R. Taylor
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia
Marina Konopleva,Twee Tsao,Peter Ruvolo,Irina Stiouf,Zeev Estrov,Clinton E. Leysath,Shourong Zhao,David Harris,Shirong Chang,C. Ellen Jackson,Mark Munsell,Nanjoo Suh,Gordon Gribble,Tadashi Honda,W. Stratford May,Michael B. Sporn,Michael Andreeff
PHAGOCYTES
RED CELLS
TRANSPLANTATION
BRIEF REPORTS
Liposomal amphotericin B (AmBisome) compared with amphotericin B ± FMLP induces significantly less in vitro neutrophil aggregation with granulocyte–colony-stimulating factor/dexamethasone–mobilized allogeneic donor neutrophils: Presented in part at the American Society of Blood and Marrow Transplantation, Keystone, CO, February 2001
Clinical Trials & Observations
Brief Report
CORRESPONDENCE
Terminal plasmocytoid differentiation of malignant B cells induced by autotumor-reactive CD4+ T cells in one case of splenic marginal zone B-cell lymphoma
Thierry Bonnefoix,Jian-Qing Mi,Pascal Perron,Mary Callanan,Cosima Semoun,Mireille Favre,Jean-Charles Renversez,Marie-France Sotto,Dominique Leroux,Jean-Jacques Sotto
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals